10:30 |
0544.
|
In vivo measurement of T1 and
T2 relaxation
times in healthy human prostate at 7T
Marnix C. Maas1, Miriam W. Lagemaat2,
Stephan Orzada3,4, Thiele Kobus2,
Oliver Kraff3, Stefan Maderwald3,
Andreas K. Bitz3,4, Mark E. Ladd3,4,
and Tom W.J. Scheenen2,3
1Radiology, Radboud University Nijmegen
Medical Centre, Nijmegen, Netherlands, 2Radiology,
Radboud University Nijmegen Medical Centre, Nijmegen,
GLD, Netherlands, 3Erwin
L. Hahn Institute for Magnetic Resonance Imaging,
University Duisburg-Essen, Essen, Germany, 4Diagnostic
and Interventional Radiology and Neuroradiology,
University Hospital Essen, Essen, Germany
Knowledge of T1 and T2 relaxation times can aid the
development and optimization of dedicated pulse
sequences for imaging and spectroscopy at ultra-high
field (≥7T). We have measured these quantities in human
prostate and surrounding tissues at 7T in healthy
volunteers using progressive saturation gradient echo
imaging with fixed TR and varying flip angle for T1 and
multiple-contrast spin-echo imaging for T2. The results
suggested a TE of 60–70 ms for optimum contrast between
the prostate peripheral zone and transition zones in
fast spin-echo imaging, which was indeed shown to yield
contrast between these tissues.
|
10:42 |
0545. |
MR T1 Imaging
on Human Prostate Cancer
Xiang He1, Serter Gumus1, Ayaz
Aghayev1, Jie Zheng2, and Kyongtae
Ty Bae1
1Department of Radiology, University of
Pittsburgh, Pittsburgh, PA, United States, 2Mallinckrodt
Institute of Radiology, Washington University in St
Louis, St Louis, Missouri, United States
In this study, we developed and applied a T1ρ sequence
to image the prostate in healthy normal controls and
patients. Our results demonstrated that T1ρ
quantification is feasible in 3T MR scanner without the
utilization of an endorectal coil. While peripheral zone
T2 and T1ρ maps were often homogenous in healthy control
subjects, large regional heterogeneity can been also
observed due to the variations on granular structure.
The discrepancy of T2 and T1ρ behavior in prostate
peripheral lesion area in patients is likely due to
increased cellular content. This may provide additional
information to improve the diagnosis of prostate cancer.
|
10:54 |
0546. |
Sodium Imaging of the
Prostate at 3T
Daniel Hausmann1, Simon Konstandin2,
Frank G Zöllner2, Stefan Haneder1,
Friedrich Wetterling2, Armin M Nagel3,
Dietmar J Dinter1, Stefan O Schönberg1,
and Lothar R Schad2
1Institute of Clinical Radiology and Nuclear
Medicine, University Medicine Mannheim, Mannheim,
Germany, 2Computer
Assisted Clinical Medicine, University Medicine
Mannheim, Mannheim, Germany, 3Department
of Medical Physics in Radiology, German Cancer Research
Center, Heidelberg, Germany
The mutiparametric MR imaging approach of the prostate
involves functional sequences to increase the
specificity of the evaluation of prostatic lesions. The
purpose of this study was to evaluate the feasibility of
23Na imaging and the feasibililty of quantification as a
tool of possible additional value for multiparametric
imaging of the prostate in a clinical setting in human
volunteers at 3 T. Eight volunteers 23-34 years old
(mean = 28 years) were enrolled. This study suggests
that sodium imaging on a clinical 3T scanner might be an
appropriate, noninvasive method for imaging of the human
prostate. Further developments of the coil systems are
necessary to increase spatial resolution, to reduce
examination time and to enable a more accurate and
reliable quantification. Moreover, clinical studies are
necessary to evaluate if changes of the sodium levels
are apparent in prostate cancer.
|
11:06 |
0547. |
Diagnostic modelling of
multi-parametric MRI as a radiological tool to predict
transition zone prostate cancer
Nikolaos Dikaios1, Taiki Fujiwara2,
Mohamed Abd Alazeez3, David Atkinson4,
and Shonit Punwani2
1Department of Medical Physics and
Bioengineering, University College London, London,
Greater London, United Kingdom, 2Department
of Radiology, University College London Hospital, 3Department
of Urology, University College London Hospital, 4Centre
for Medical Imaging, University College London
Multi-parametric MRI has a reported sensitivity of 73%
and specificity of 89% for detection of tumour within
the peripheral zone of the prostate. However, benign
prostatic hypertrophy as commonly found in the
transition zone produces signal changes that make the
radiologists detection of anterior gland tumour more
difficult. Our study derived a predictive model for
classification of suspected sites of anterior gland
disease based on clinical (age, PSA, gland volume, PSA
density), quantitative MRI parameters (ADC, contrast
enhanced, T2 image signal) and textural features of MR
images (entropy, contrast, co-occurance); and compared
the performance of this model for detection of tumour
against a consensus radiologist opinion.
|
11:18 |
0548. |
Assessment of abnormal ADC
matched voxels with DCE parameters for characterization of
prostate cancer at 3T
Fiona M Fennessy1,2, Andriy Fedorov1,
Sandeep N Gupta3, William M Wells1,
Robert V Mulkern1,4, and Clare M Tempany1
1Radiology, Brigham and Women's Hospital,
Boston, MA, United States, 2Radiology,
Dana Farber Cancer Institute, Boston, MA, United States, 3GE
Global Research Center, Niskayuna, NY, United States, 4Radiology,
Children's Hospital Boston, Boston, MA, United States
We sought to determine if Ktrans and ve differed within
ADC-matched prostate tumor voxels, confirmed by
pathology at radical prostatectomy. A deformable
registration technique was used to recover image
distortions on DWI, registered to the DCE series. We
found a significant difference between tumor and normal
tissue for ADC, Ktrans , and ve. Using Logistic
regression analysis, Ktrans has a contributory role to
ADC for tumor detection. However, weak correlations
between both Ktrans and ve and the ADC values,
underscoring the different pathophysiological processes
assessed with DWI and DCE, and need for a
multiple-parameter strategy approach for prostate tumor
assessment.
|
11:30 |
0549. |
Diffusion tensor magnetic
resonance tractography of the prostate: feasibility for
mapping neurovascular anatomy
Daniel Jason Aaron Margolis1, Benjamin
Ellingson2, Shyam Natarajan3,
Robert Reiter4, Taryar Zaw1, Peter
Schulam4, Steven Raman1, and David
Finley5
1Department of Radiology, UCLA David Geffen
School of Medicine, Los Angeles, CA, United States, 2Department
of Radioloyg, UCLA David Geffen School of Medicine, 3Department
of Bioengineering, UCLA David Geffen School of Medicine,
Los Angeles, CA, United States, 4Department
of Urology, UCLA David Geffen School of Medicine, 5Department
of Urology, Kaiser Permanente Los Angeles
Eight men scheduled to prostatectomy underwent
endorectal multiparametric magnetic resonance imaging
(MRI) of the prostate with DTI. DTI tractography was
successfully performed in all eight patients,
visualizing fiber tracts around the prostate. DTI
tractography of the prostate effectively visualized
periprostatic fiber tract anatomy. Variation in tract
distribution existed within individual patients and
between patients. Some patients had disproportionately
tract mass from one side of the prostate to the other.
These findings have potential applicability for the
generation of patient-specific pre-operative nerve
sparing plans for RP and for the quantitative evaluation
of potency outcomes.
|
11:42 |
0550.
|
Fast Real-Time Tracking
Using a POCC Algorithm for 3T MR-Guided Transrectal Prostate
Biopsy: A Feasibility Study.
Patrik Zamecnik1, Martijn Schouten2,
Axel Krafft3, Florian Maier4,
Heinz-Peter Schlemmer5, Jelle O. Barentsz6,
Michael Bock7, and Jurgen J. Fütterer6
1Radiology, German Cancer Research Center (DKFZ),
Heidelberg, Germany, Germany, 2Radboud
University Nijmegen Medical Centre, Nijmegen,
Netherlands, 3Department
of Radiological Sciences, St. Jude Children's Research
Hospital, Memphis, United States, 4Department
of Medical Physics in Radiology, German Cancer Research
Center (DKFZ), Heidelberg, Germany, 5Radiology,
German Cancer Research Center (DKFZ), Heidelberg,
Germany,6Radiology, Radboud University
Nijmegen Medical Centre, Nijmegen, Netherlands, 7Medical
Physics, Dept. of Radiology, University Hospital
Freiburg, Freiburg, Germany
In this feasibility study a safe, easy and precise
instrument guidance using the POCC based sequence for
automatic needle-guide tracking in transrectal 3 T MR-guided
prostate biopsies was demonstrated. The combination of
very easy handling, good tumor detection rates
comparable with other MR-guided prostate biopsy
techniques, use of standard, commercial available
devices and short procedure times is very promising and
making this approach attractive for clinical routine.
|
11:54 |
0551. |
Comparison of TRUS vs. MRI
guided biopsy in MRI apparent prostate cancers: Preliminary
Results
Adam J Jung1, Fergus V. Coakley2,
Antonio C. Westphalen3, Daniel B. Vigneron3,
and John Kurhanewicz4
1Radiology and Biomedical Imaging, University
of California San Francisco, San Francisco, CA, United
States, 2Department
of Radiology and Biomedical Imaging, University of
California San Francisco, 3Department
of Radiology and Biomedical Imaging, University of
California San Francisco, San Francisco, CA, United
States, 4University
of California San Francisco
The primary socioeconomic challenge in caring for
patients with prostate cancer is our limited ability to
accurately characterize the disease as indolent or
aggressive at the time of presentation, and stratify
management from active surveillance through definitive
surgery or radiation accordingly. A major contributing
factor to this problem is the known inaccuracy in
disease detection and characterization by systematic
transrectal ultrasound-guided biopsy, even though this
is the current standard of care for diagnosis. We
demonstrate that multiparametric MRI supplemented by
MRI-guided biopsy can improve both disease detection and
characterization, and may ultimately improve our ability
to deliver personalized patient care in men with
prostate cancer.
|
12:06 |
0552. |
Prostate cancer detection
rate: MRSI directed TRUS biopsy versus increasing number of
cores in clinically challenging group of men with PSA in the
gray zone of 4-10 ng/ml
Durgesh Kumar Dwivedi1, Tarun Javali2,
Rajeev Kumar2, Sanjay Thulkar3,
Sanjay Sharma3, Amit K. Dinda4,
and Naranamangalam R. Jagannathan1
1Department of NMR & MRI Facility, All India
Institute of Medical Sciences, New Delhi, Delhi, India, 2Department
of Urology, All India Institute of Medical Sciences, New
Delhi, Delhi, India, 3Department
of Radio-diagnosis, All India Institute of Medical
Sciences, New Delhi, Delhi, India, 4Department
of Pathology, All India Institute of Medical Sciences,
New Delhi, Delhi, India
Raised serum prostate specific antigen (PSA) may not
reflect the presence of prostate cancer (PCa) and
transrectal ultrasound (TRUS) has limited sensitivity in
PCa detection. MRSI has the potential to detect PCa
based on metabolic differences. We performed a
retrospective case controlled study on 278 men prior to
biopsy with PSA in the range of 4-10 ng/ml. Our study
revealed that MRSI directed TRUS biopsy increases PCa
detection rate (2.9 times) compared to standard TRUS
guided core (6 or 12) biopsy in patients with PSA in the
range of 4-10 ng/ml.
|
12:18 |
0553. |
Biologically-guided
radiation treatment of the prostate using 1H-MRSI
permission withheld
Niranjan Venugopal1,2, Lawrence Ryner3,4,
Keith Nakonechny2, and Boyd McCurdy2,4
1Physics and Astronomy, University of
Manitoba, Winnipeg, Manitoba, Canada, 2Medical
Physics, CancerCare Manitoba, Winnipeg, Manitoba,
Canada,3National Research Council Institute
for Biodiagnostics, 4Physics
and Astronomy, University of Manitoba
Using intensity modulated radiation therapy (IMRT), we
can now accurately deliver radiation doses to dominant
intraprostatic lesions as identified by 1H-MRSI. Using a
modified tumour control probability (TCP) formalism,
which includes the 1H-MRSI data, we determine the
optimal dose distribution that would enable equivalent
control of the prostate cancer by escalating the dose to
the localized DIL. The TCP and normal tissue
complication probability (NTCP) for both plans were
calculated, and compared. The result of this study
indicates that optimizing the dose to the prostate
according to 1H-MRSI information is possible, and that
it can be used to logically derive new prescription
doses leading to improved TCP.
|
|